Loratadine
- Product NDC
- 68788-8605
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Loratadine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA211718
- Marketing category
- ANDA
- Substance
- LORATADINE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 68788-8605-0 | 10 TABLET in 1 BOTTLE (68788-8605-0) | 20240313 | | No | Historical |
| 68788-8605-1 | 14 TABLET in 1 BOTTLE (68788-8605-1) | 20240313 | | No | Historical |
| 68788-8605-3 | 30 TABLET in 1 BOTTLE (68788-8605-3) | 20240313 | | No | Historical |
| 68788-8605-5 | 15 TABLET in 1 BOTTLE (68788-8605-5) | 20240313 | | No | Historical |
| 68788-8605-9 | 90 TABLET in 1 BOTTLE (68788-8605-9) | 20240313 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| d778c4d2-184a-4dc8-9351-66d81d0618f2 | Loratadine tablets USP, 10mg/antihistamine | Preferred Pharmaceuticals Inc. | 2025-07-23 | HUMAN OTC DRUG LABEL | 2 |